Detalles de la búsqueda
1.
Impaired TRPM3-dependent calcium influx and restoration using Naltrexone in natural killer cells of myalgic encephalomyelitis/chronic fatigue syndrome patients.
J Transl Med
; 20(1): 94, 2022 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35172836
2.
The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients.
J Transl Med
; 19(1): 306, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34266470
3.
A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome.
J Transl Med
; 19(1): 81, 2021 02 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33596913
4.
A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease.
J Transl Med
; 18(1): 290, 2020 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32727475
5.
Correction to: A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease.
J Transl Med
; 18(1): 407, 2020 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33109201
6.
Identification and characterisation of transient receptor potential melastatin 2 and CD38 channels on natural killer cells using the novel application of flow cytometry.
BMC Immunol
; 20(1): 14, 2019 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31077146
7.
Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients.
J Transl Med
; 17(1): 401, 2019 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31796045
8.
A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID).
BMC Neurol
; 19(1): 207, 2019 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31445522
9.
Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Mol Med
; 24(1): 44, 2018 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30134818
10.
Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Review.
Int J Environ Res Public Health
; 18(20)2021 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34682454
11.
A preliminary investigation of nutritional intake and supplement use in Australians with myalgic encephalomyelitis/chronic fatigue syndrome and the implications on health-related quality of life.
Food Nutr Res
; 652021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34262415
12.
Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Healthcare (Basel)
; 9(5)2021 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34065013
13.
Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Int J Environ Res Public Health
; 18(22)2021 11 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34831634
14.
Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
Front Immunol
; 12: 687806, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34326841
15.
A systematic review of neurological impairments in myalgic encephalomyelitis/ chronic fatigue syndrome using neuroimaging techniques.
PLoS One
; 15(4): e0232475, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32353033
16.
Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
Front Immunol
; 10: 2545, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31736966
17.
A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome.
Syst Rev
; 8(1): 279, 2019 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31727160
18.
Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.
BMC Pharmacol Toxicol
; 19(1): 12, 2018 03 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29587879
19.
Deregulation of calcium homeostasis in Bcr-Abl-dependent chronic myeloid leukemia.
Oncotarget
; 9(41): 26309-26327, 2018 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29899861
Resultados
1 -
19
de 19
1
Próxima >
>>